Molecular mechanisms of hemoglobin F induction

International Journal of Hematology-Oncology and Stem Cell Research

Volumn 5, Issue 4, 2011, Pages 5-9

  Hagh, Majid Farshdousti ^a   Fard, Ali Dehghani ^b   Saki, Najmaldin ^c   Shahjahani, Mohammad ^b   Kaviani, Saied ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

thalassemia; Expression; Hemoglobin F; Induction

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; BETA GLOBIN; BUTYRIC ACID; GAMMA GLOBIN; HEMOGLOBIN F; HYDROXYUREA; LENALIDOMIDE; POMALIDOMIDE; PROTEIN MYB; REACTIVE OXYGEN METABOLITE; THALIDOMIDE;

BCL11A GENE; BETA GLOBIN GENE; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; GAMMA GLOBIN GENE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HBG2 GENE; HBS1L GENE; HUMAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MYB GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; QUANTITATIVE TRAIT LOCUS; REVIEW; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; UPREGULATION;

EID: 84861580815     PISSN: 17351243     EISSN: 20082207     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010; 5: 11.
2. Perrine SP, Castaneda SA, Chui DH, Faller DV, Berenson RJ, Siritanaratku N, et al. Fetal Globin Gene Inducers: Novel Agents and New Potential. Ann N Y Acad Sci.2010Aug; 1202: 15.64-8.
3. Rahim F, Saki N. Age-specific Cutoff in Discriminating Iron Deficiency Anemia from beta-Thalassemia Traits. IJBC. 2010; 2(4): 197.
4. Fathallah H, Atweh GF. Induction of fetal hemoglobin in the treatment of sickle cell disease. Hematology Am Soc Hematol Educ Program. 2006:58-62.
5. Gaziev J, Lucarelli G. Stem Cell Transplantation for Hemoglobinopathies. Curr Opin Pediatr. 2003 Feb; 15(1): 24-31.
6. Thein SL, Wainscoat JS, Sampietro M, Old JM, Thalassaemia Intermedia with a beta-Globin Gene Haplotype. Br J Haematol. 1987 Mar; 65(3): 367-73.
7. Efremov GD, Gjorgovski I, Stojanovski N, Diaz-Chico JC, Harano T, Kutlar F, et al. One Haplotype is Associated with the Swiss Type of Hereditary Persistence of Fetal Hemoglobin in the Yugoslavian Population. Hum Genet. 1987 Oct; 77(2): 132-6.
8. Garner C, Tatu T, Game L, Cardon L, Spector T, Farrall M, et al. A Candidate Gene Study of F Cell Levels in Sibling Pairs Using a Joint Linkage and Association Analysis. GeneScreen. 2000; 1: 9-14.
9. Thein SL, Menzel S, Peng X, Best S, Jiang J, Close J, et al. Intergenic Variants of HBS1L-MYB are Responsible for a Major Quantitative Trait Locus on Chromosome 6q23 Influencing Fetal Hemoglobin Levels in Adults. Proc Natl Acad Sci USA. 2007 Jul 3; 104 (27): 11346-51.
10. Menzel S, Garner C, Gut I, Matsuda F, Yamaguchi M, Heath S, et al. A QTL Influencing F Cell Production Maps to a Gene Encoding a Zinc-Finger Protein on Chromosome 2p15. Nat Genet. 2007 Oct; 39(10): 1197-9.
11. Lettre G, Sankaran VG, Bezerra MA, Araujo AS, Uda M, Sanna S, et al. DNA Polymorphisms at the BCL11A, HBS1L-MYB, and beta-Globin Loci Associate with Fetal Hemoglobin Levels and Pain Crises in Sickle Cell Disease. Proc Natl Acad Sci U S A. 2008 Aug 19; 105 (33): 11869-74.
12. Jiang J, Best S, Menzel S, Silver N, Lai MI, Surdulescu GL, et al. cMYB is Involved in the Regulation of Fetal Hemoglobin Production in Adults. Blood. 2006 Aug 1; 108(3): 1077-83.
13. Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, et al. Genome-wide Association Study Shows BCL11A Associated with Persistent Fetal Hemoglobin and Amelioration of the Phenotype of beta-Thalassemia. Proc Natl Acad Sci USA. 2008 Feb 5; 105(5): 1620-5.
14. Sedgewick AE, Timofeev N, Sebastiani P, So JC, Ma ES, Chan LC, et al. BCL11A is a Major HbF Quantitative Trait Locus in Three Different Populations with beta-Hemoglobinopathies. Blood Cells Mol Dis. 2008 Nov-Dec; 41(3): 255-8.
15. Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, Van Handel B, et al. Human Fetal Hemoglobin Expression is Regulated by the Developmental Stage-specific Repressor BCL11A. Science. 2008 Dec 19; 322(5909): 1839-42.
16. Sankaran VG, Xu J, Ragoczy T, Ippolito GC, Walkley CR, Maika SD, et al. Developmental and Species-divergent Globin Switching are Driven by Cappellini D, Fiorelli G, et al. Association of BCL11A. Nature. 2009 Aug 27; 460 (7259): 1093-7.
17. Chen Z, Luo HY, Steinberg MH, Chui DH. BCL11A Represses HBG Transcription in K562 Cells. Blood Cells Mol Dis. 2009 Mar-Apr; 42(2): 1-9.
18. Atweh GF, Sutton M, Nassif I, Boosalis V, Dover GJ, Wallenstein S, et al. Sustained Induction of Fetal Hemoglobin by Pulse Butyrate Therapy in Sickle Cell Disease. Blood. 1999 Mar 15; 93(6): 1790-7.
19. Atweh GF, DeSimone J, Saunthararajah Y, Fathallah H, Weinberg RS, Nagel RL, et al. Hemoglobinopathies. Hematology Am Soc Hematol Educ Program. 2003: 14-39.
20. Migliaccio AR, Rotili D, Nebbioso A, Atweh G, Mai A. Histone Deacetylase Inhibitors and Hemoglobin F Induction in beta-Thalassemia. Int J Biochem Cell Biol. 2008; 40(11): 2341-7.
21. Hsiao CH, Li W, Lou TF, Baliga BS, Pace BS. Fetal Hemoglobin Induction by Histone Deacetylase Inhibitors Involves Generation of Reactive Oxygen Species. Exp Hematol. 2006 Mar; 34(3): 264-73.
22. Saunthararajah Y, Hillery CA, Lavelle D, Molokie R, Dorn L, Bressler L, et al. Effects of 5-aza-2'-deoxycytidine on Fetal Hemoglobin Levels, Red Cell Adhesion, and Hematopoietic Differentiation in Patients with Sickle Cell Disease. Blood. 2003 Dec 1; 102(12): 3865-70.
23. DeSimone J, Koshy M, Dorn L, Lavelle D, Bressler L, Molokie R, et al. Maintenance of Elevated Fetal Hemoglobin Levels by Decitabine during Dose Interval Treatment of Sickle Cell Anemia. Blood. 2002 Jun 1; 99(11): 3905-8.
24. Stamatoyannopoulos G, Blau CA, Nakamoto B, Josephson B, Li Q, Liakopoulou E, et al. Fetal Hemoglobin Induction by Acetate, a Product of Butyrate Catabolism. Blood. 1994 Nov 1; 84 (9): 3198-204.
25. Moutouh-de Parseval LA, Verhelle D, Glezer E, Jensen-Pergakes K, Ferguson GD, Corral LG, et al. Pomalidomide and Lenalidomide Regulate Erythropoiesis and Fetal Hemoglobin Production in Human CD34+ Cells. J Clin Invest. 2008 Jan; 118(1): 248-58.
26. Aerbajinai W, Zhu J, Gao Z, Chin K, Rodgers GP. Thalidomide Induces Gamma-globin Gene Expression through Increased Reactive Oxygen Species-mediated p38 MAPK Signaling and Histone H4 Acetylation in Adult Erythropoiesis. Blood. 2007 Oct 15; 110(8): 2864-71.
27. Ahmadvand M, Noruzinia M, Soleimani M, Kaviani S, Abroun S, Dehghanifard A, et al. In vitro Induction of Gamma Globin Gene in Erythroid Cells Derived from CD133+ by Thalidomide and Sodium Butyrate. Genetics in the Third Millenium. 2011; 9(2): 2373-78.
28. Li X, Liu X, Wang J, Wang Z, Jiang W, Reed E, et al. Thalidomide down-Regulates the Expression of VEGF and bFGF in Cisplatin-Resistant Human Lung Carcinoma Cells. Anticancer Res. 2003 May-Jun; 23(3B): 2481-7.
29. Dehghani Fard A, Kaviani S, Noruzinia M, Soleimani M, Abroun S, Hajifathali A, et al. Changing Patterns of Histone H3 Methylation Following Treatment of CD133+ Derived Erythroid Precursor Cells with Sodium Butyrate and Thalidomide. Iranian Journal of Blood and Cancer (IJBC).
30. Masera N, Tavecchia L, Capra M, Cazzaniga G, Vimercati C, Pozzi L, et al. Optimal Response to Thalidomide in a Patient with Thalassaemia Major Resistant to Conventional Therapy. Blood Transfus. 2010 Jan; 8(1): 63-5.
31. Atashi A, Soleymani M, Kaviani S, Hajfathali A, Arefian E. In vitro Induction of Fetal Hemoglobin in Erythroid Cells Derived from CD133+ Cells by Transforming Growth Factor-β and Stem Cell Factor. Iranian Journal of Biotechnology. 2008; 6(3): 157-63.